&nbsp;

Jan 2025

Regimen

PEME+AMIV(MNT)

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Drugs Used:

pemetrexed,

amivantamab (Unfunded)

Quick Link(s):

Regimen Monograph

Jan 2025

Regimen

PEMB(MNT)

Cancer Type:

Gastrointestinal,

Esophagus,

Gastric / Stomach

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - First-line Treatment of Advanced HER2-negative Esophageal, Gastric, and Esophagogastric Junction Carcinoma

Drugs Used:

pembrolizumab

Quick Link(s):

Regimen Monograph

Jan 2025

Drug

PANitumumab

Other Name(s): Vectibix®

Quick Link(s):

Jan 2025

Drug

pembrolizumab

Other Name(s): Keytruda®

Quick Link(s):

Jan 2025

Regimen

PIRT

Cancer Type:

Hematologic,

Leukemia - Chronic Lymphocytic (CLL)

Intent: Palliative

Drugs Used:

pirtobrutinib (Unfunded)

Quick Link(s):

Regimen Monograph

Feb 2025

Guidelines and Advice

Ontario Cervical Screening Program: Interim guidance to support the transition years following the launch of human papillomavirus testing in Ontario: Cervical screening and colposcopy recommendations for people ages 21 to 24

Status: Current

Updated

Mar 2025

Guidelines and Advice

Ontario Cervical Screening Program recommendations for cervical screening and colposcopy with human papillomavirus testing in Ontario

Updated

Mar 2025

Guidelines and Advice

Ontario Cervical Screening Program: Guidance for Vaginal Vault Testing

Status: Current

Updated

Mar 2025

Drug

pegylated liposomal DOXOrubicin

Other Name(s): Caelyx®

Quick Link(s):

Mar 2025

Regimen

PGLDX

Cancer Type:

Gynecologic,

Ovary

Intent: Palliative

Funding:

New Drug Funding Program

Liposomal DOXOrubicin - Single Agent Treatment of Platinum Sensitive Ovarian Fallopian Tube or Primary Peritoneal Cancer

New Drug Funding Program

Liposomal Doxorubicin - Platinum-Resistant Ovarian Fallopian Tube or Primary Peritoneal Cancer

pegylated liposomal DOXOrubicin

Drugs Used:

Quick Link(s):

Regimen Monograph

Mar 2025

Regimen

PGLDX

Cancer Type:

Sarcoma,

Kaposi's Sarcoma

Intent: Palliative

Funding:

New Drug Funding Program

Liposomal Doxorubicin - HIV-positive Kaposi's Sarcoma

pegylated liposomal DOXOrubicin

Drugs Used: